Related Experiment Video

Updated: Nov 12, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.9K

Regulating Polθ in Breast Cancer

Denisse Carvajal-Maldonado1, Richard D Wood2,3

  • 1Department of Epigenetics & Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, Texas.

Cancer Research
|March 16, 2021
PubMed

Insights

Researchers identified ZEB1 as a key regulator of DNA polymerase θ (POLQ) expression. This finding is crucial for understanding the theta-mediated end-joining (TMEJ) pathway, important in cancer survival and drug development.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • DNA polymerase θ (POLQ) is central to the theta-mediated end-joining (TMEJ) DNA repair pathway.
  • TMEJ pathway activity is essential for the survival and growth of certain cancers.
  • Understanding TMEJ regulation is critical for developing targeted cancer therapies and biomarkers.

Purpose of the Study:

  • To identify the regulatory mechanisms controlling POLQ expression and TMEJ activity.
  • To investigate the role of transcription factors in regulating the TMEJ pathway.

Main Methods:

  • Identification of transcription regulators for the POLQ gene.
  • Analysis of TMEJ activity in cellular models.
  • Characterization of ZEB1's role in POLQ expression.

Main Results:

  • Prodhomme and colleagues identified the transcription factor ZEB1 as the first known regulator of POLQ expression.
  • ZEB1 directly influences the activity of the TMEJ pathway.
  • This discovery provides a new molecular target for modulating TMEJ in cancer.

Conclusions:

  • ZEB1 is a critical transcription regulator of the DNA repair pathway TMEJ.
  • Targeting ZEB1 offers a potential strategy for cancer treatment by inhibiting TMEJ-dependent tumors.
  • Further research into ZEB1 and TMEJ regulation will advance cancer therapy development.

More Related Videos

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.3K
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

1.2K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.5K